Synonyms: ABT-493 | ABT493 | Maviret® | Mavyret® (glecaprevir + pibrentasvir)
glecaprevir is an approved drug (EMA & FDA (2017))
Compound class:
Synthetic organic
Comment: Glecaprevir is an orally available anti-hepatitis C virus (HCV) drug. It is a direct-acting inhibitor of the HCV NS3/4A protease, and thereby targets viral RNA replication.
|
|
Bioactivity Comments |
Potent antiviral activity against major HCV genotypes in vitro and in vivo [1]. |